Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer

por Jayachandran, Priya, Knox, Susan J., Garcia-Cremades, Maria, Savić, Radojka M.
Publicado 2021

Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis

por Ali, Ali Mohamed, Wallender, Erika, Hughes, Emma, Dorsey, Grant, Savic, Radojka M.
Publicado 2023

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

por Dooley, Kelly E., Hanna, Debra, Mave, Vidya, Eisenach, Kathleen, Savic, Radojka M.
Publicado 2019

Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis

por Fors, John, Strydom, Natasha, Fox, William S., Keizer, Ron J., Savic, Radojka M.
Publicado 2020

Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations

por Hughes, Emma, Wallender, Erika, Mohamed Ali, Ali, Jagannathan, Prasanna, Savic, Radojka M.
Publicado 2021

Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials

por Imperial, Marjorie Z., Phillips, Patrick P. J., Nahid, Payam, Savic, Radojka M.
Publicado 2021

Pharmacokinetic analysis across studies to drive knowledge‐integration: A tutorial on individual patient data meta‐analysis (IPDMA)

por van Wijk, Rob C., Imperial, Marjorie Z., Savic, Radojka M., Solans, Belén P.
Publicado 2023

Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis

por Savic, Radojka M., Novakovic, Ana M., Ekblom, Marianne, Munafo, Alain, Karlsson, Mats O.
Publicado 2017

Model‐informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma

por Savic, Radojka M., Green, Michelle L., Jorga, Karin, Zager, Michael, Washington, Carla B.
Publicado 2022

Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action

por Green, Michelle L., Savic, Radojka M., Tonda, Margaret, Jorga, Karin, Washington, Carla B.
Publicado 2022

Application of population pharmacokinetics to cladribine

por Lindemalm, Synnöve, Savic, Radojka M, Karlsson, Mats O, Juliusson, Gunnar, Liliemark, Jan, Albertioni, Freidoun
Publicado 2005

Standard Error of Empirical Bayes Estimate in NONMEM® VI

por Kang, Dongwoo, Bae, Kyun-Seop, Houk, Brett E., Savic, Radojka M., Karlsson, Mats O.
Publicado 2012

Response to “Quantitative Clinical Pharmacology INPUT to SARS‐CoV‐2 Therapeutics Should be Based on Robust Data”

por Garcia‐Cremades, Maria, Solans, Belen P., Hughes, Emma, Ernest, Jacqueline P., Wallender, Erika, Savic, Radojka M.
Publicado 2020

Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics

por Vora, Bianca, Brackman, Deanna J., Zou, Ling, Garcia‐Cremades, Maria, Sirota, Marina, Savic, Radojka M., Giacomini, Kathleen M.
Publicado 2021

Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis

por Yun, Hwi-Yeol, Chang, Vincent, Radtke, Kendra K, Wang, Qianwen, Strydom, Natasha, Chang, Min Jung, Savic, Radojka M
Publicado 2021

Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing

por Garcia‐Cremades, Maria, Solans, Belen P., Hughes, Emma, Ernest, Jacqueline P., Wallender, Erika, Aweeka, Francesca, Luetkemeyer, Anne F., Savic, Radojka M.
Publicado 2020

Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis

por Solans, Belén P, Béranger, Agathe, Radtke, Kendra, Mohamed, Ali, Mirzayev, Fuad, Gegia, Medea, Linh, Nguyen Nhat, Schumacher, Samuel G, Nahid, Payam, Savic, Radojka M
Publicado 2023

Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV‐Coinfected Children in India: Recommendations for Dose Modifications

por Guiastrennec, Benjamin, Ramachandran, Geetha, Karlsson, Mats O., Kumar, A.K. Hemanth, Bhavani, Perumal Kannabiran, Gangadevi, N. Poorana, Swaminathan, Soumya, Gupta, Amita, Dooley, Kelly E., Savic, Radojka M.
Publicado 2018

Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis

por Gewitz, Andrew D., Solans, Belén P., Mac Kenzie, William R., Heilig, Chad, Whitworth, William C., Johnson, John L., Nsubuga, Pheona, Dorman, Susan, Weiner, Marc, Savic, Radojka M.
Publicado 2021

Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization

por Strydom, Natasha, Gupta, Sneha V., Fox, William S., Via, Laura E., Bang, Hyeeun, Lee, Myungsun, Eum, Seokyong, Shim, TaeSun, Barry, Clifton E., Zimmerman, Matthew, Dartois, Véronique, Savic, Radojka M.
Publicado 2019